ClinicalTrials.gg
CompletedNCT03351218AGENT10Updated Dec 4, 2025

Agency in Dystonia

An interventional study of Behavioral testing - computerized tasks in Dystonia, Primary, sponsored by Institut National de la Santé Et de la Recherche Médicale, France. Completed at 1 site in France. Open to participants aged 15 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-04.

Sponsored by Institut National de la Santé Et de la Recherche Médicale, France · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Non-randomized
Ages
15 Years to 65 Years
Sex
All
01

Study summary

In this study, using computerized cognitive assessments combined with multi-modal neuroimaging approach investigators aim to address three specific questions on patients with cervical and myoclonus dystonia:

(i) investigate various aspects of the sense of agency and relationship to the severity of dystonia symptoms, (ii) characterize the possible link between abnormalities of movement perception and alteration of sense of agency in dystonia, (iii) (identify the neuronal underpinnings of the defective sense of agency in dystonia.

Read the detailed description

This is a single-centre, two-group ( dystonia and control), case-control study using behavioural and novel multimodal neuroimaging techniques to address the study aims.

The battery of the tasks will include explicit-agency tasks, a visual discrimination task on objects movement perception. The magnetic resonance acquisition protocol will include MP2RAGE structural (10 min duration), multi echo (3 echo times) multiband (MB factor 4) resting state functional neuroimaging (15 minutes duration) and multi shell diffusion imaging sequence (15 minutes duration)

02

Conditions studied

  • Dystonia, Primary

Browse trials for

03

In context

Dystonic Disorders

95 studies on the registry are indexed under Dystonic Disorders; 19 are open to participants now.

This study's enrollment of 76 is above the median of 24 across 45 interventional studies indexed under Dystonic Disorders.

Browse Dystonic Disorders studies →

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France is the lead sponsor of 378 studies on the registry; 81 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of isolated adult-onset cervical dystonia (CD) or myoclonus dystonia (MD);
  • duration of disease of more than one year
  • no botulinum toxin injection for at least three months before the study
  • normal or corrected-to-normal vision.

Exclusion criteria

Exclusion Criteria

  • any neurological history except for dystonia,
  • history of dopamine antagonist treatment,
  • secondary dystonia,
  • dystonia in the upper limbs,
  • inability to maintain gaze straight.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
76 participants (actual)

Study arms

  • Other
    Patients

    25 patients with cervical and 25 patients with myoclonus dystonia

    Behavioral: Behavioral testing - computerized tasks

  • Other
    Controls

    50 healthy volunteers matched to patents ( age, sex)

    Behavioral: Behavioral testing - computerized tasks

Interventions

  • BehavioralBehavioral testing - computerized tasks

    Cognitive behavioral testing and cerebral MRI

06

What researchers measure

Primary outcomes

  1. agency tasks behavioral outcome measures

    response time

    Time frame: throughout study completion, an average 2 years

  2. agency tasks behavioral outcome measures

    response accuracy in tasks trials

    Time frame: throughout study completion, an average 2 years

Secondary outcomes

  1. MRI measures

    cortical thickness

    Time frame: throughout study completion, an average 2 years

  2. MRI measures

    basal ganglia volume

    Time frame: throughout study completion, an average 2 years

07

Study locations

1 site
  • Centre d'investigation Clinique
    Paris, Île-de-France Region 75013, France
08

References and documents

Publications

  • Tarrano C, Lamy JC, Delorme C, McGovern EM, Atkinson-Clement C, Brochard V, Thobois S, Tranchant C, Grabli D, Degos B, Corvol JC, Pedespan JM, Krystkoviak P, Houeto JL, Degardin A, Defebvre L, Apartis E, Vidailhet M, Roze E, Worbe Y. Tactile Temporal Discrimination Is Impaired in Myoclonus-Dystonia. Mov Disord. 2020 Dec;35(12):2356-2357. doi: 10.1002/mds.28253. Epub 2020 Sep 22. No abstract available. PubMed 32960985 ↗
  • Tarrano C, Wattiez N, Delorme C, McGovern EM, Brochard V, Thobois S, Tranchant C, Grabli D, Degos B, Corvol JC, Pedespan JM, Krystkoviak P, Houeto JL, Degardin A, Defebvre L, Valabregue R, Vidailhet M, Pouget P, Roze E, Worbe Y. Visual sensory processing is altered in myoclonus dystonia. Mov Disord. 2020 Jan;35(1):151-160. doi: 10.1002/mds.27857. Epub 2019 Sep 30. PubMed 31571302 ↗
  • Zito GA, Tarrano C, Jegatheesan P, Ekmen A, Beranger B, Rebsamen M, Hubsch C, Sangla S, Bonnet C, Delorme C, Meneret A, Degos B, Bouquet F, Brissard MA, Vidailhet M, Gallea C, Roze E, Worbe Y. Somatotopy of cervical dystonia in motor-cerebellar networks: Evidence from resting state fMRI. Parkinsonism Relat Disord. 2022 Jan;94:30-36. doi: 10.1016/j.parkreldis.2021.11.034. Epub 2021 Nov 30. PubMed 34875561 ↗
  • Zito GA, Tarrano C, Ouarab S, Jegatheesan P, Ekmen A, Beranger B, Valabregue R, Hubsch C, Sangla S, Bonnet C, Delorme C, Meneret A, Degos B, Bouquet F, Apoil Brissard M, Vidailhet M, Hasboun D, Worbe Y, Roze E, Gallea C. Fixel-Based Analysis Reveals Whole-Brain White Matter Abnormalities in Cervical Dystonia. Mov Disord. 2023 Jul;38(7):1187-1196. doi: 10.1002/mds.29425. Epub 2023 May 6. PubMed 37148555 ↗
  • Zito GA, Roze E, Tarrano C, Ouarab S, Jegatheesan P, Ekmen A, Beranger B, Valabregue R, Hubsch C, Sangla S, Bonnet C, Delorme C, Meneret A, Degos B, Bouquet F, Apoil Brissard M, Vidailhet M, Hasboun D, Pouget P, Worbe Y, Gallea C. Abnormal Connectivity of the Head Neural Integrator in Cervical Dystonia. Mov Disord. 2025 Nov;40(11):2321-2330. doi: 10.1002/mds.70014. Epub 2025 Sep 5. PubMed 40910449 ↗
  • Atkinson-Clement C, Tarrano C, Porte CA, Wattiez N, Delorme C, McGovern EM, Brochard V, Thobois S, Tranchant C, Grabli D, Degos B, Corvol JC, Pedespan JM, Krystkoviak P, Houeto JL, Degardin A, Defebvre L, Valabregue R, Rosso C, Apartis E, Vidailhet M, Pouget P, Roze E, Worbe Y. Dissociation in reactive and proactive inhibitory control in Myoclonus dystonia. Sci Rep. 2020 Aug 18;10(1):13933. doi: 10.1038/s41598-020-70926-x. PubMed 32811896 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03351218
Responsible party
Sponsor
First posted
Nov 22, 2017
Start date
Oct 23, 2017
Primary completion
Oct 15, 2020
Completion
Dec 20, 2022
Last update
Dec 4, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion